Kejako Company

Kejako is a Swiss company that was founded in 2015 and focuses on developing a non-invasive solution for presbyopia, which is the gradual loss of visual accommodation. Their approach combines simulation and minimally invasive treatment to provide an all-in-one solution for patients seeking to maintain their quality of life.

Estimated Revenue: $1M to $10M
Funding Status: Seed
Industry: P4 Medicine
Investors Number: 2
Technology: P4 Medicine
Founded Date: 2015
Investor Type: For Profit
Headquarters: Geneve, Geneve
Total Funding: CHF700K
Last Funding Type: Seed
Employee Number: 1-10